Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cannabidiol Pharmacokinetics”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Early research (Phase 1)Study completedNCT06648031
What this trial is testing

Comparison of the Safety, Efficacy and Pharmacokinetics of DehydraTECH -CBD and DehydraTECH-GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants

Who this might be right for
Type2diabetes
Lexaria Bioscience Corp. 148
Early research (Phase 1)Study completedNCT02286986
What this trial is testing

Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy

Who this might be right for
Epilepsy
University of Utah 26
Early research (Phase 1)Study completedNCT06578455
What this trial is testing

A Pharmacokinetic Study to Compare CBD-NE to Epidyolex in Healthy Adult Volunteers Under Both Fed and Fasted Conditions

Who this might be right for
CBD PharmacokineticsHealthy Participants
dsm-firmenich Switzerland AG 32
Large-scale testing (Phase 3)Ended earlyNCT04485104
What this trial is testing

Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures

Who this might be right for
Seizure in Participants With Tuberous Sclerosis ComplexSeizure in Participants With Dravet SyndromeSeizure in Participants With Lennox-Gastaut Syndrome
Jazz Pharmaceuticals 3
Not applicableWithdrawnNCT02910297
What this trial is testing

The Pharmacokinetics of Cannabidiol (CBD) and Its Effects in Children With Severe Epilepsy

Who this might be right for
Dravet SyndromeLennox Gastaut Syndrome
Gillette Children's Specialty Healthcare
Early research (Phase 1)Study completedNCT01893424
What this trial is testing

Bioequivalence Assessment of Oral Administration Vs. Oral Spray of a Cannabinoids (Tetrahydrocannabinol and Cannabidiol)

Who this might be right for
Pain
Hadassah Medical Organization 12
Very early researchUnknownNCT03877991
What this trial is testing

Bioequivalence Assessment of Cannabidiol (CBD) Administrated in Oral Formulations

Who this might be right for
Pain
Hadassah Medical Organization 12
Very early researchActive Not RecruitingNCT04878627
What this trial is testing

Role of CBD in Regulating Meal Time Anxiety in Anorexia Nervosa

Who this might be right for
Anorexia Nervosa
University of California, San Diego 40
Early research (Phase 1)Study completedNCT01887301
What this trial is testing

Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients

Who this might be right for
Hepatic Impairment
Jazz Pharmaceuticals 32
Not applicableStudy completedNCT04971837
What this trial is testing

Interaction Between Cannabidiol, Meal Ingestion, and Liver Function

Who this might be right for
MetabolismLiver FunctionPharmacokinetics
Colorado State University 26
Large-scale testing (Phase 3)Study completedNCT02091375
What this trial is testing

Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)

Who this might be right for
EpilepsyDravet Syndrome
Jazz Pharmaceuticals 120
Early research (Phase 1)Study completedNCT03164512
What this trial is testing

The Pharmacokinetics and Pharmacodynamics of Oral and Vaporized Cannabidiol

Who this might be right for
Cannabidiol Pharmacokinetics
Johns Hopkins University 19
Testing effectiveness (Phase 2)Study completedNCT02091206
What this trial is testing

A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)

Who this might be right for
EpilepsyDravet Syndrome
Jazz Pharmaceuticals 34
Early research (Phase 1)Study completedNCT06854783
What this trial is testing

Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers

Who this might be right for
Pharmacokinetics
Tiamat Australia Pty Ltd 20
Early research (Phase 1)Ended earlyNCT03471559
What this trial is testing

Cannabidiol - an in Vivo Innovative Drug Delivery Study

Who this might be right for
Pharmacokinetics, Bioavailability
Central Institute of Mental Health, Mannheim 8
Not applicableStudy completedNCT06286839
What this trial is testing

Study of Cannabidiol (CBD) in Healthy Volunteers

Who this might be right for
Immune System and Related DisordersImmune System Diseases
NextEvo Inc. 26
Early research (Phase 1)Active Not RecruitingNCT05742724
What this trial is testing

The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol

Who this might be right for
CannabisChronic Kidney DiseasesDialysis
McMaster University 24
Early research (Phase 1)Study completedNCT07186283
What this trial is testing

Pharmacokinetic Study of a Novel Cannabidiol (CBD) Formulation in Healthy Volunteers

Who this might be right for
PK in Healthy Volunteers
NW PharmaTech Ltd 14
Testing effectiveness (Phase 2)Ended earlyNCT03336242
What this trial is testing

Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures

Who this might be right for
Childhood Absence Epilepsy
Radius Pharmaceuticals, Inc. 20
Not applicableStudy completedNCT07359976
What this trial is testing

Pharmacokinetic Evaluation of a Natural CBD Extract

Who this might be right for
Pharmacokinetics of CBD Extract, Oral and Topical Administrations
University of Utah 20
Next Page